Genmab — Oktober 2022
-
Godmorgen.
-
USA/lukning: Indeks i plus trods høj inflation efter seks røde dage https://www.proinvestor.com/investornyt/890279/usa-lukning-indeks-i-plus-trods-hoj-inflation-efter-seks-rode-dage
-
Asien: Flyvende aktiemarkeder efter dramatisk Wall Street-vending https://www.proinvestor.com/investornyt/890362/asien-flyvende-aktiemarkeder-efter-dramatisk-wall-street-vending
-
Aktier: U-vending viser paniske og kortsigtede investorer, der reagerer som under finanskrisen - Der er pyntet op til dansk aktiefest https://www.proinvestor.com/boards/106936
-
Aktier/tendens: Danske aktier har noget til gode efter U-vending i USA https://www.proinvestor.com/investornyt/890380/aktier-tendens-danske-aktier-har-noget-til-gode-efter-u-vending-i-usa
-
New Ph3- A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) https://clinicaltrials.gov/ct2/show/NCT05578976
-
Foruden, at du skal drikke danskvand sammen med Nohope?
-
Min faldende kniv fra i går, er behændig afhændet uden det medførte læsioner. Det bliver fejret med rødvin senere i dag og måske stuetemperaturen bliver hævet til 21 grader fra 19..... men kun måske
-
Abstracts from the 2022 Lymphoma, Leukemia and Myeloma Congress October 18–22, 2022 , P48-51 = Epco https://onlinelibrary.wiley.com/doi/full/10.1002/ajh.26736
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind